Skip to main content
Year archive

IMRICOR MEDICAL SYSTEMS INC. — 2025 filings

All 70 regulatory filings released by IMRICOR MEDICAL SYSTEMS INC. (IMR) in 2025, sourced directly from the official regulator.

70 Filings
2025 Period
2025 filings (70)
Filing Released Lang
Charite to Become 2nd Site for VISABL-VT 2 pages 239.5KB
Regulatory Filings
2025-12-18 English
UVA Health to Become Second U.S. Site for VISABL-AFL 2 pages 236.6KB
Regulatory Filings
2025-12-14 English
Imricor Appoints Aldo Denti to Board of Directors 3 pages 243.5KB
Board/Management Information
2025-11-09 English
Initial Director's Interest Notice 2 pages 225.1KB
Director's Dealing
2025-11-09 English
First in Human Ischemic VT Ablation Performed in iCMR 4 pages 396.8KB
Regulatory Filings
2025-11-03 English
Cleansing Notice 3 pages 251.5KB
Regulatory Filings
2025-10-27 English
Application for quotation of securities - IMR 6 pages 18.3KB
Capital/Financing Update
2025-10-26 English
Imricor Q3 CY25 Quarterly Activities Report and Appendix 4C 9 pages 621.7KB
Interim / Quarterly Report Q3 2025
2025-10-21 English
Canaccord Drug & Device Conference Noosa 2025 Presentation 12 pages 1.4MB
Investor Presentation
2025-10-20 English
Imricor Performs World's First PFA Ablation in the iCMR 3 pages 272.2KB
Regulatory Filings
2025-10-19 English
Notification of cessation of securities - IMR 4 pages 14.8KB
Share Issue/Capital Change
2025-10-12 English
Notification regarding unquoted securities - IMR 6 pages 18.9KB
Share Issue/Capital Change
2025-10-09 English
Imricor Completes Human Factors Study for FDA 3 pages 248.7KB
Regulatory Filings
2025-09-17 English
Application for quotation of securities - IMR 6 pages 18.5KB
Share Issue/Capital Change
2025-09-14 English
Application for quotation of securities - IMR 6 pages 18.5KB
Share Issue/Capital Change
2025-09-07 English
Submission of FDA 510(k) Approval for Vision-MR Diagnostic 2 pages 235.2KB
Regulatory Filings
2025-08-31 English
Release from Voluntary Escrow 2 pages 236.1KB
Regulatory Filings
2025-08-27 English
Appendix 4D and Half Year Report & Accounts 37 pages 1.5MB
Interim / Quarterly Report H1 2025
2025-08-25 English
Imricor releases Half Year Results for 1H 2025 3 pages 296.2KB
Interim / Quarterly Report H1 2025
2025-08-25 English
H1 FY25 Results Investor Presentation 23 pages 2.3MB
Investor Presentation
2025-08-25 English
FY25 1H Results Webinar Notification 1 page 221.3KB
Report Publication Announcement
2025-08-14 English
Canaccord 45th Annual Growth Conference Presentation 33 pages 2.4MB
Investor Presentation
2025-08-12 English
Imricor Q2 CY25 Quarterly Activities Report and Appendix 4C 9 pages 737.6KB
Interim / Quarterly Report Q2 2025
2025-07-27 English
Regulatory and Business Update 4 pages 229.6KB
Regulatory Filings
2025-07-09 English
Notification regarding unquoted securities - IMR 6 pages 18.9KB
Share Issue/Capital Change
2025-07-02 English
Imricor Receives CE Mark Approval for NorthStar 2 pages 157.8KB
Regulatory Filings
2025-06-09 English
Notification regarding unquoted securities - IMR 6 pages 19.6KB
Share Issue/Capital Change
2025-06-05 English
Appendix 3Y - SW 2 pages 235.3KB
Director's Dealing
2025-06-05 English
Appendix 3Y - MT 2 pages 285.8KB
Director's Dealing
2025-06-05 English
Appendix 3Y - PM 3 pages 395.6KB
Director's Dealing
2025-05-26 English
Appendix 3Y - MT 2 pages 236.7KB
Director's Dealing
2025-05-26 English
Appendix 3Y - AM 3 pages 238.1KB
Director's Dealing
2025-05-26 English
Application for quotation of securities - IMR 7 pages 21.5KB
Share Issue/Capital Change
2025-05-21 English
Chair's Address for AGM 3 pages 238.2KB
AGM Information
2025-05-13 English
AGM Presentation Slides 33 pages 907.6KB
AGM Information
2025-05-13 English
Results of Meeting 4 pages 341.3KB
Declaration of Voting Results & Voting Rights Announcements
2025-05-13 English
Release from Voluntary Escrow 2 pages 236.2KB
Regulatory Filings
2025-05-04 English
Procedures Commence at Semmelweis University 2 pages 244.5KB
Capital/Financing Update
2025-04-30 English
Imricor Q1 CY25 Quarterly Activities Report and Appendix 4C 10 pages 786.4KB
Interim / Quarterly Report Q1 2025
2025-04-22 English
CE Mark Approval for Advantage-MR under EU's MDR 2 pages 246.3KB
Regulatory Filings
2025-04-16 English
Change in substantial holding 4 pages 222.2KB
Major Shareholding Notification
2025-04-15 English
Notification regarding unquoted securities - IMR 6 pages 18.5KB
Share Issue/Capital Change
2025-04-13 English
Imricor Commences VISABL-VT Clinical Trial 2 pages 244.8KB
Regulatory Filings
2025-04-10 English
Notification of cessation of securities - IMR 4 pages 14.8KB
Transaction in Own Shares
2025-04-09 English
Annual Report to shareholders 69 pages 1.6MB
Annual Report FY 2024
2025-04-09 English
Appendix 4G and Corporate Governance Statement 24 pages 677.5KB
Regulatory Filings
2025-04-09 English
Notice of Annual Stockholders Meeting and CDI Voting Form 39 pages 1.3MB
AGM Information
2025-04-09 English
Becoming a substantial holder 4 pages 222.0KB
Major Shareholding Notification
2025-03-31 English
Cleansing Notice 3 pages 223.9KB
Capital/Financing Update
2025-03-27 English
Ceasing to be a substantial holder 2 pages 206.6KB
Major Shareholding Notification
2025-03-27 English
Application for quotation of securities - IMR 5 pages 16.5KB
Share Issue/Capital Change
2025-03-26 English
Application for quotation of securities - IMR 6 pages 18.3KB
Share Issue/Capital Change
2025-03-25 English
Successful Completion of A$70 Million Capital Raise 3 pages 275.7KB
Capital/Financing Update
2025-03-19 English
Proposed issue of securities - IMR 5 pages 18.2KB
Capital/Financing Update
2025-03-19 English
Equity Raising Presentation 45 pages 4.6MB
Investor Presentation
2025-03-19 English
Reinstatement to Official Quotation 1 page 89.1KB
Capital/Financing Update
2025-03-19 English
Suspension from Quotation 2 pages 223.3KB
Capital/Financing Update
2025-03-18 English
Trading Halt 2 pages 222.6KB
Capital/Financing Update
2025-03-16 English
Submission of Second Module to FDA for PMA Products 2 pages 246.6KB
Regulatory Filings
2025-03-03 English
Appendix 4E and FY24 Financial Accounts 38 pages 1.3MB
Annual Report FY 2024
2025-02-26 English
Imricor Releases FY24 Results 4 pages 845.4KB
Annual Report FY 2024
2025-02-26 English
FY24 Results Investor Presentation 41 pages 4.5MB
Investor Presentation
2025-02-26 English
CE Mark Approval for 2nd Gen Vision MR Ablation Catheter 2 pages 246.2KB
Regulatory Filings
2025-02-18 English
FY24 Results Webinar 2 pages 243.0KB
Report Publication Announcement
2025-02-16 English
Application for quotation of securities - IMR 6 pages 18.3KB
Share Issue/Capital Change
2025-02-06 English
Cleansing Notice 3 pages 224.1KB
Regulatory Filings
2025-02-06 English
Release from Voluntary Escrow 2 pages 234.8KB
Regulatory Filings
2025-01-30 English
Imricor Q4 CY24 Quarterly Activities Report and Appendix 4C 10 pages 565.7KB
Interim / Quarterly Report Q4 2024
2025-01-22 English
Notification regarding unquoted securities - IMR 6 pages 18.5KB
Share Issue/Capital Change
2025-01-12 English
Notification of cessation of securities - IMR 4 pages 14.8KB
Transaction in Own Shares
2025-01-08 English